Search results for "PROGNOSIS"

showing 10 items of 2052 documents

Prestroke antiplatelet therapy and early prognosis in stroke patients: the Dijon Stroke Registry

2012

Background and purpose Previous antiplatelet therapy (APT) in cardiovascular prevention is common in patients with first-ever stroke. We aimed to evaluate the prognostic value of APT on early outcome in stroke patients. Methods All first-ever strokes from 1985 to 2011 were identified from the population-based Stroke Registry of Dijon, France. Demographic features, risk factors, prestroke treatments and clinical information were recorded. Multivariate analyses were performed to evaluate the associations between pre-admission APT and both severe handicap at discharge, and mortality at 1 month and 1 year. Results Among the 4275 patients, 870 (20.4%) were previously treated with APT. Severe han…

Malemedicine.medical_specialtyStroke registryMultivariate analysisPopulationKaplan-Meier EstimateLower riskRisk FactorsInternal medicinemedicineHumansRegistrieseducationStrokeAgedAged 80 and overeducation.field_of_studybusiness.industryHazard ratioOdds ratioMiddle AgedPrognosismedicine.diseaseConfidence intervalSurgeryStrokeEarly DiagnosisTreatment OutcomeNeurologyFemaleFranceNeurology (clinical)businessPlatelet Aggregation InhibitorsEuropean Journal of Neurology
researchProduct

Detection of Left Ventricular Systolic Dysfunction in Cardiac Amyloidosis with Strain Rate Echocardiography .

2006

Background We examined the potential role of Doppler myocardial imaging including tissue velocity imaging, strain imaging, and strain rate imaging for detection of left ventricular systolic dysfunction in cardiac amyloidosis (CA) and determined the minimum dataset required to make the diagnosis. Methods and Results Doppler myocardial imaging was performed in 103 patients with amyloidosis (AL). Peak longitudinal systolic tissue velocity, systolic strain rate (sSR), and systolic strain (sS) were determined for 16 left ventricular segments. Radial and circumferential sSR and sS were also measured. Patients with increased left ventricular wall thickness were classified with advanced-CA, and the…

Malemedicine.medical_specialtySystoleBiopsyHeart VentriclesSeverity of Illness IndexDiagnosis DifferentialVentricular Dysfunction LeftSystolic strainInternal medicineHumansMedicineRadiology Nuclear Medicine and imagingAgedRetrospective StudiesTissue velocityEchocardiography Doppler PulsedObserver Variationbusiness.industryAmyloidosisReproducibility of ResultsStrain imagingMiddle AgedStrain ratePrognosismedicine.diseaseMyocardial ContractionSettore MED/11 - Malattie Dell'Apparato CardiovascolareCardiac amyloidosisAMYLOIDOSISStrain rate imagingCardiologyCardiology and Cardiovascular MedicinebusinessBlood Flow VelocityLeft ventricular wallFollow-Up Studies
researchProduct

Differential prognostic effect of systolic blood pressure on mortality according to left-ventricular function in patients with acute heart failure.

2009

Aims To evaluate the relationship between systolic blood pressure (SBP) and long-term mortality in patients with acute heart failure (AHF) stratified by ejection fraction (LVEF): reduced (≤40%) vs. preserved (≥50%). Methods and results We studied 1049 consecutive patients admitted with AHF. Systolic blood pressure was determined in the emergency department. Left-ventricular ejection fraction was categorized as ≤40% (n = 288), 41–49% (n = 174), or ≥50% (n = 587). Cox regression analysis was used for multivariable analysis. Mean age and SBP were 73 ± 11 years and 150 ± 36 mmHg, respectively. During a median follow-up of 18 months, 290 deaths (33.1%) were identified. Higher SBP was associated …

Malemedicine.medical_specialtySystoleBlood PressureVentricular Function LeftInternal medicinemedicineHumansIn patientcardiovascular diseasesSystoleAgedProportional Hazards ModelsHeart FailureEjection fractionVentricular functionProportional hazards modelbusiness.industryStroke VolumeStroke volumemedicine.diseasePrognosisBlood pressureTreatment OutcomeHeart failureAcute DiseaseCardiologyFemaleCardiology and Cardiovascular Medicinebusinesscirculatory and respiratory physiologyFollow-Up StudiesEuropean journal of heart failure
researchProduct

FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment

2006

Specific patterns of cortical glucose metabolism disturbances and increased CSF phospho-tau (p-tau(181)) concentrations could be demonstrated to predict cognitive decline and shift to dementia in amnestic mild cognitive impairment (MCI). But comparisons of both diagnostic tools have not been undertaken so far. The aim of the study was to compare (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) findings and CSF phospho-tau (p-tau(181)) measurements in the prediction of cognitive deterioration and conversion to dementia in MCI. During follow-up (mean 19 months) eight of 16 patients (50%) showed progressive cognitive decline, and four patients shifted to dementia. Patholog…

Malemedicine.medical_specialtyTau proteinNeuroscience (miscellaneous)tau ProteinsKaplan-Meier EstimateSeverity of Illness IndexStereotaxic TechniquesCentral nervous system diseaseImaging Three-DimensionalDegenerative diseaseFluorodeoxyglucose F18Internal medicinemental disordersSeverity of illnessImage Processing Computer-AssistedmedicineHumansDementiaRadiology Nuclear Medicine and imagingLongitudinal StudiesCognitive declineAgedPsychiatric Status Rating ScalesbiologyCognitive disorderPrognosismedicine.diseasePsychiatry and Mental healthPositron-Emission TomographyStereotaxic techniquebiology.proteinCardiologyDementiaFemaleCognition DisordersMental Status SchedulePsychologyNeuroscienceBiomarkersFollow-Up StudiesPsychiatry Research: Neuroimaging
researchProduct

Aortic intramural hemorrhage visualized by transesophageal echocardiography: Findings and prognostic implication

1994

Abstract Objectives. This study describes the transesophageal echocardiographic and follow-up findings in patients with aortic intramural hemorrhage. Background. Localized aortic intramural hemorrhage resulting in layered thickening of the aortic wall seems to represent a variant of acute aortic dissection without communication or a typical moving intimal flap. In autopsy studies this variant, attributed to a rupture of the van vasorum, has been described in 5% to 10% of patients with dissection. Methods. In a prospective transesophageal echocardiographic study in patients with aortic dissection performed between 1986 and 1991, the diagnosis of intramural hemorrhage was established in 15 of…

Malemedicine.medical_specialtyTime FactorsAortic RuptureAorta ThoracicAutopsyDissection (medical)Asymptomaticmedicine.arteryAscending aortamedicineHumansProspective StudiesAortaAgedAortic dissectionAortaAortic Aneurysm ThoracicVascular diseasebusiness.industryPrognosismedicine.diseaseAortic AneurysmSurgeryAortic DissectionDescending aortacardiovascular systemFemaleRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessEchocardiography TransesophagealFollow-Up StudiesJournal of the American College of Cardiology
researchProduct

Clinical findings of Takotsubo cardiomyopathy: results from a multicenter international study

2008

BACKGROUND: Takotsubo cardiomyopathy consists of reversible systolic left ventricular apical ballooning associated with chest pain. Electrocardiographic abnormalities and the minimal rise of serum cardiac markers are similar to those in acute myocardial infarction, but without evidence of myocardial ischemia or injury. To date, many reports concerning this kind of acute reversible heart failure have been published, but the information available about the management of affected patients is scarce and the clinical data are incomplete. AIMS: In the present study, we report a collection of 40 patients who were affected by Takotsubo cardiomyopathy obtained in a multicentric international study, …

Malemedicine.medical_specialtyTime FactorsCardiomyopathyChest painCoronary AngiographySeverity of Illness IndexTakotsubo cardiomiopathyDiagnosis DifferentialElectrocardiographyTakotsubo CardiomyopathyInternal medicineSeverity of illnessmedicineHumanscardiovascular diseasesMyocardial infarctionAgedmedicine.diagnostic_testbusiness.industryclinical and instrumental patternGated Blood-Pool ImagingStroke VolumeGeneral MedicineStroke volumemedicine.diseasePrognosisMyocardial ContractionSettore MED/11 - Malattie Dell'Apparato CardiovascolareGated Blood-Pool ImagingEchocardiographynatural historydiagnostic criteriacardiovascular systemCardiologyExercise TestFemaleDifferential diagnosismedicine.symptomCardiology and Cardiovascular MedicinebusinessElectrocardiographymanagementFollow-Up Studies
researchProduct

Efficacy and Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin in Atrial Fibrillation in Different Age Subgroups

2014

This study aims to estimate the cost-effectiveness of dabigatran 150 mg twice daily versus warfarin for stroke and systemic embolism risk reduction in patients with nonvalvular atrial fibrillation initiating treatment before age 75 (<75), at or after age 75 (≥75), and the overall population (All) from a US Medicare payer perspective. Clinical event rates by age cohort with dabigatran or warfarin for safety-on-treatment and intent-to-treat populations were estimated from Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY). An economic model was adapted using these data to evaluate the impact of starting age on clinical and economic outcomes. Costs were obtained from Medicare p…

Malemedicine.medical_specialtyTime FactorsCost effectivenessCost-Benefit AnalysisMedicareAntithrombinsDrug Administration ScheduleDrug CostsDabigatranThromboembolismInternal medicineAtrial FibrillationmedicineHumansIn patientcardiovascular diseasesStrokeAgedbusiness.industryIncidenceFollow up studiesWarfarinSystemic embolismAtrial fibrillationPrognosismedicine.diseaseUnited StatesDabigatranbeta-AlanineCardiologyBenzimidazolesFemalebusinessCardiology and Cardiovascular MedicineFollow-Up Studiesmedicine.drugThe American Journal of Cardiology
researchProduct

Effects of clinical and laboratory variables at admission and of in-hospital treatment with cardiovascular drugs on short term prognosis of ischemic …

2011

Abstract Introduction No information exists, to our knowledge, about the possible role of cardiovascular drug administration in the acute phase of ischemic stroke and possible effects on stroke outcome. The aim of our study was to evaluate the relationship between in-hospital treatment with cardiovascular drugs in patients with acute ischemic stroke and some outcome indicators. Methods and Results 1096 subjects enrolled in the GIFA study, who had a main discharge diagnosis of ischemic stroke represent the final sample. Drugs considered for the analysis were the following: ACE-inhibitors (ACEI), angiotensin II receptor blockers (ARBs), statins, calcium-channel-blockers (CCBs), antiplatelet (…

Malemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismHypercholesterolemiaMedicine (miscellaneous)Angiotensin II Receptor BlockersCharlson indexAngiotensin-Converting Enzyme InhibitorsComorbidityBrain IschemiaInternal medicineActivities of Daily LivingmedicineHumansIn patientcardiovascular diseasesStrokeGeriatric AssessmentAgedRetrospective StudiesNutrition and Dieteticsbusiness.industryCardiovascular AgentsHeparinmedicine.diseaseCalcium Channel BlockersPrognosisStrokeHospital treatmentItalyIschemic strokeHypertensionPhysical therapyFunctional statusFemaleCardiology and Cardiovascular MedicinebusinessCognition DisordersPlatelet Aggregation Inhibitorsmedicine.drugNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Cardio‐Renal Biomarker Soluble Urokinase‐Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Pat…

2020

Background Risk stratification among patients with coronary artery disease ( CAD ) is of considerable interest due to the potential to guide secondary preventive therapies. Thus, we evaluated the predictive value of soluble urokinase‐type plasminogen activator receptor (su PAR ) levels for cardiovascular mortality and nonfatal myocardial infarction in patients with CAD . Methods and Results Plasma levels of su PAR were measured in a cohort of 1703 patients with documented CAD as evidenced by coronary angiography—including 626 patients with acute coronary syndrome and 1077 patients with stable angina pectoris. Cardiovascular death and/or nonfatal myocardial infarction were defined as main o…

Malemedicine.medical_specialtyTime FactorsEpidemiologyMyocardial InfarctionRenal functionCoronary Artery Disease030204 cardiovascular system & hematologyKidneyRisk AssessmentReceptors Urokinase Plasminogen Activatorsoluble urokinase‐type plasminogen activator receptorTroponin CCoronary artery disease03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsGermanyInternal medicineSecondary PreventionmedicineHumanscardiovascular diseasesMyocardial infarctionReceptorAgedOriginal Research030304 developmental biologyUrokinase0303 health sciencesbusiness.industryMiddle AgedPrognosismedicine.diseaseTroponinC-Reactive ProteinHeart Disease Risk FactorsCardiologybiomarkerBiomarker (medicine)FemaleKidney DiseasesCardiology and Cardiovascular MedicinebusinessPlasminogen activatorBiomarkersGlomerular Filtration Ratemedicine.drugJournal of the American Heart Association
researchProduct

Low Systolic Blood Pressure and Mortality in Elderly Patients After Acute Myocardial Infarction

2020

Background Optimal blood pressure in elderly patients after acute myocardial infarction is still a matter of debate. In a prospective observational study, we aimed to identify optimal systolic blood pressure during the 48 first hours after admission for acute myocardial infarction and its prognostic value for cardiovascular mortality. Methods and Results From the Observatoire des Infarctus de Côte d'Or survey, all consecutive patients aged &gt;75 years admitted for an acute myocardial infarction in a coronary care unit from 2012 to 2015 and discharged alive were included (n=814). Exclusion criteria were in‐hospital death, cardiogenic shock, and end‐stage renal disease. Average systolic blo…

Malemedicine.medical_specialtyTime FactorsEpidemiologyMyocardial Infarctionacute myocardial infarction030204 cardiovascular system & hematologyelderly patientsRisk Assessment03 medical and health sciencesPatient Admission0302 clinical medicinecardiovascular mortalityInternal medicinemedicineCoronary Heart DiseaseHumansProspective Studies030212 general & internal medicineMyocardial infarctionNon-ST Elevated Myocardial InfarctionOriginal ResearchAgedCardiovascular mortalityAged 80 and overbusiness.industryAge Factorsblood pressurePrognosismedicine.diseaseBlood pressureHeart Disease Risk FactorsCardiologyST Elevation Myocardial InfarctionFemaleObservational studyCardiology and Cardiovascular MedicinebusinessJournal of the American Heart Association
researchProduct